P2RY12 and atrial fibrillation: The encouraging experience in AF patients who underwent percutaneous coronary interventions and were successfully managed with DOACs and single P2Y12 inhibitors prompted us to explore a strategy consisting of a brief period of periprocedural triple antithrombotic therapy followed by DOACs + P2Y12 inhibitors in patients with AF undergoing CAS.